Bay Street News, October, 2020

Enrollment in first three cohorts complete; final cohort now enrolling with plans to initiate a pivotal study before year-endData continues […]

RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company […]

BridgeBio to Acquire All Outstanding Shares of Eidos it Does Not Already OwnAgreement Brings BridgeBio’s Clinical Development and Commercial Development […]

BALA CYNWYD, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane (NASDAQ: HLNE) was […]

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company […]

Advancing Phase 2 and Phase 3 studies of the company’s targeted C3 therapy in C3G / IC-MPGN, rare kidney diseases […]

IRVING, Texas, Oct. 05, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (“Forterra” or “the Company”) (NASDAQ: FRTA), a leading manufacturer of […]

BERKELEY HEIGHTS, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a [...]

THE WOODLANDS, Texas, Oct. 05, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) in advance of investor meetings, today […]

CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) —  Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]